Polymer-based Prefilled Syringe Market

Polymer-based Prefilled Syringe Market Overview

The polymer-based prefilled syringe market is likely to register a CAGR of 9% during the forecast period, and is anticipated to reach a market share of US$ 15.75 Bn in 2032, from US$ 5.6 Bn in 2020, due to the shift in patients care with the progress of biopharmaceutical drug products.

The market demand for polymer-based prefilled syringes is growing due to the requirement for convenience, minimum errors in clinical medicine, and awareness of the required dose.

The demand for high-quality, dependable packaging is growing as more sensitive medications hit the polymer-based prefilled syringe market.

The polymer-based prefilled syringe is cost-effective, safe, and provides precise dose administration while maintaining a high-quality standard, which stimulates the sales of polymer-based prefilled syringes. The demand for polymer-based prefilled syringe is driven by the demand for flexibility, higher tolerance power, and break resistance that are brought up in the market in appealing designs. 

They have exceptional transparency and are impact resistant, which improves the polymer-based prefilled syringe market share. Therapy is self-administered in developing countries, necessitating the development of new installation solutions that meet the needs of the customers and promotes the sales of polymer-based prefilled syringe.

The prefilled syringe made of polymer is effective in delivering the essential medicament, therefore improving the sales of polymer-based prefilled syringe.

What Leads to the Growth of the Polymer-Based Prefilled Syringe Market?

The market demand for polymer-based prefilled syringe is predicted to grow due to its ability to provide reliable and predictable medication performance. To treat chronic diseases, there was a need for a shift in treatment from hospitals to home care.

The expansion in sales of the polymer-based prefilled syringe has been propelled by the shift in patient care brought about by the advancement of biopharmaceutical medicinal products. When mistreated, glass prefilled syringes can shatter, allowing heavy metals to leak out, fueling the expansion of the polymer-based prefilled syringe market.

What Restraints the Growth of the Polymer-Based Prefilled Syringe Market?

Despite the fact that polymer-based prefilled syringes have had a significant impact on the healthcare industry, there are some constraints that may limit the demand for polymer-based prefilled syringe.

They have a higher gas permeability than glass prefilled syringes, which can let atmospheric air into the syringe, making glass prefilled syringes an excellent barrier, impacting the sales of polymer-based prefilled syringe

What are the Opportunities Prevailing in the Polymer-Based Prefilled Syringe Market?

Due to the requirement for enhanced health issues, glass is regarded to be more dominating than polymer. Despite the fact that glass prefilled syringes have more advantages than polymer-based prefilled syringes, the demand for polymer-based prefilled syringe is predicted to develop due to their convenience of use and low cost.

In comparison to the polymer-based prefilled syringe market, the glass prefilled syringe market is expected to grow slowly. This market's net sales of polymer-based prefilled syringe could be boosted by innovation that provides a superior moisture barrier.

Ismail Sutaria

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which is the Leading Region in the Polymer-Based Prefilled Syringe Market?

Countries in Europe, North America, and Asia Pacific have the highest drug consumption and a large pharmaceutical market.

Thus, demand for polymer-based prefilled syringe is likely to grow. The polymer-based prefilled syringe market share in developed nations such as the United States, Italy, and the United Kingdom is predicted to increase at a healthy rate during the forecast period.

It was ascribed to the strong demand for polymer-based prefilled syringe used in pharmaceutical packaging. The sales of polymer-based prefilled syringe in developing nations such as India, China, and others are predicted to grow in response to rising demand to reduce medical errors and boost convenience.

What is the Competitive Outlook of the Polymer-Based Prefilled Syringe Market?

Ajinomoto Bio-Pharma, Inc, Aptar Pharma (India) Pvt. Ltd., Baxter International Inc., Biocorp, Enable Injections, Inc, Nipro Corp, SHL Medical, Shandong Weigao Group, Stevanato Group, Unilife Corporation are some key players in the polymer-based prefilled syringe market, which contribute to the substantial polymer-based prefilled syringe market share.

• In order to increase revenue and market share, multinational corporations are forming partnerships, collaborations, and mergers. Continuous research and development operations are carried out in order to generate innovative products and gain a larger polymer-based prefilled syringe market share.
• Becton, Dickinson and Company announced a cooperation with the Biomedical Advanced Research and Development Authority (BARDA) in July 2020.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Sign-Up

Scope of Report